Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 71 | 68 | −3 |
| Shares | 40.1M | 39.9M | −209.8K (−0.5%) |
| Value | $226.6M | $281.3M | +$54.7M (+24.1%) |
New holders (10)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 120,647 | $850.6K | 0.00% |
| Long Corridor Asset Management Ltd | 40,000 | $282.0K | 0.25% |
| Jump Financial, LLC | 16,898 | $119.1K | 0.00% |
| EntryPoint Capital, LLC | 15,893 | $112.0K | 0.10% |
| PDT Partners, LLC | 13,955 | $98.4K | 0.01% |
| STRS Ohio | 3,100 | $21.0K | 0.00% |
| GAMMA Investing LLC | 52 | $367 | 0.00% |
| Nisa Investment Advisors, LLC | 13 | $92 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 6 | $42 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (13)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 135,000 | $762.8K |
| Caption Management, LLC | 90,690 | $512.4K |
| HRT Financial LP | 63,204 | $357.0K |
| Sphera Funds Management Ltd. | 48,511 | $274.1K |
| Susquehanna International Group, LLP | 46,387 | $262.1K |
| UBS Oconnor LLC | 44,247 | $250.0K |
| Balyasny Asset Management LLC | 38,802 | $219.2K |
| Squarepoint Ops LLC | 17,462 | $98.7K |
| SG Americas Securities, LLC | 12,257 | $69.0K |
| Cubist Systematic Strategies, LLC | 10,602 | $59.9K |
| Invesco Ltd. | 10,518 | $59.4K |
| Simplex Trading, LLC | 10,043 | $56.0K |
| Point72 Middle East FZE | 9,290 | $52.5K |